BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19284553)

  • 1. New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6.
    Garcia-Lopez R; Perea-Milla E; Garcia CR; Rivas-Ruiz F; Romero-Gonzalez J; Moreno JL; Faus V; Aguas Gdel C; Diaz JC
    Trials; 2009 Mar; 10():16. PubMed ID: 19284553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination of ascorbic acid and α-tocopherol to test the effectiveness and safety in the fragile X syndrome: study protocol for a phase II, randomized, placebo-controlled trial.
    de Diego-Otero Y; Calvo-Medina R; Quintero-Navarro C; Sánchez-Salido L; García-Guirado F; del Arco-Herrera I; Fernández-Carvajal I; Ferrando-Lucas T; Caballero-Andaluz R; Pérez-Costillas L
    Trials; 2014 Sep; 15():345. PubMed ID: 25187257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An open study evaluating the efficacy and security of magnesium and vitamin B(6) as a treatment of Tourette syndrome in children].
    García-López R; Romero-González J; Perea-Milla E; Ruiz-García C; Rivas-Ruiz F; de Las Mulas Béjar M
    Med Clin (Barc); 2008 Nov; 131(18):689-91. PubMed ID: 19087826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
    Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Nutritional Supplements Based on L-Theanine and Vitamin B6 in Children with Tourette Syndrome, with Anxiety Disorders: A Pilot Study.
    Rizzo R; Prato A; Scerbo M; Saia F; Barone R; Curatolo P
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: a 6-week randomized trial.
    Müller-Vahl KR; Schneider U; Prevedel H; Theloe K; Kolbe H; Daldrup T; Emrich HM
    J Clin Psychiatry; 2003 Apr; 64(4):459-65. PubMed ID: 12716250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial.
    Singer HS; Wendlandt J; Krieger M; Giuliano J
    Neurology; 2001 Mar; 56(5):599-604. PubMed ID: 11245709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome.
    Jankovic J; Jimenez-Shahed J; Brown LW
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):70-3. PubMed ID: 19726418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
    Bloch MH; Panza KE; Yaffa A; Alvarenga PG; Jakubovski E; Mulqueen JM; Landeros-Weisenberger A; Leckman JF
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):327-34. PubMed ID: 27027204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal and dietary therapies for primary and secondary dysmenorrhoea.
    Proctor ML; Murphy PA
    Cochrane Database Syst Rev; 2001; (3):CD002124. PubMed ID: 11687013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecopipam for Tourette Syndrome: A Randomized Trial.
    Gilbert DL; Dubow JS; Cunniff TM; Wanaski SP; Atkinson SD; Mahableshwarkar AR
    Pediatrics; 2023 Feb; 151(2):. PubMed ID: 36628546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study.
    Huang CH; Liao WL; Lee DY; Chou IC; Wang MY; Hsieh CL
    J Ethnopharmacol; 2022 May; 290():115098. PubMed ID: 35182665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Glutamate Modulators in Tic Suppression: A Double-Blind, Randomized Control Trial of D-serine and Riluzole in Tourette Syndrome.
    Lemmon ME; Grados M; Kline T; Thompson CB; Ali SF; Singer HS
    Pediatr Neurol; 2015 Jun; 52(6):629-34. PubMed ID: 26002052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and safety of plum-blossom needle therapy for Tourette syndrome: study protocol for a randomized controlled trial.
    Yu J; Ye Y; Li S; Liu J; Zhai Y; Zhang M; Liu Z
    Trials; 2015 Jul; 16():320. PubMed ID: 26220439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
    Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE
    Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
    Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled trial of risperidone in Tourette syndrome.
    Scahill L; Leckman JF; Schultz RT; Katsovich L; Peterson BS
    Neurology; 2003 Apr; 60(7):1130-5. PubMed ID: 12682319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
    Jakubovski E; Pisarenko A; Fremer C; Haas M; May M; Schumacher C; Schindler C; Häckl S; Aguirre Davila L; Koch A; Brunnauer A; Cimpianu CL; Lutz B; Bindila L; Müller-Vahl K
    Front Psychiatry; 2020; 11():575826. PubMed ID: 33324255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.